HomeProceduresDEXA Bone Density Scan

DEXA Bone Density Scan

Gold standard for osteoporosis diagnosis and monitoring — very low radiation, quick, and painless.

What Does DEXA Bone Density Scan Show?

DEXA measures bone mineral density (BMD) at the lumbar spine and proximal femur (hip) — the standard sites for osteoporosis diagnosis. Results are reported as T-score (comparison to peak bone density) and Z-score (age-matched comparison). T-score ≤ -2.5 = osteoporosis; between -1.0 and -2.5 = osteopenia.

About DEXA

⚠️ Very low ionizing radiation (much less than a chest X-ray)

DEXA (Dual-Energy X-ray Absorptiometry) uses two low-energy X-ray beams at different energy levels to calculate bone mineral density (BMD). By measuring differential absorption in bone versus soft tissue, the scanner produces a precise BMD value at the lumbar spine and proximal femur — the standard measurement sites for osteoporosis diagnosis.

Radiation & Safety: DEXA effective dose is typically 1–5 microsieverts, compared to approximately 100 microsieverts for a chest X-ray. Radiation risk is negligible and not a meaningful clinical concern.

When to Use DEXA — and When Not To

Choosing the right modality is one of the most impactful parts of the prior authorization process. Payers are more likely to approve a study when the chosen modality is clearly the most appropriate tool for the clinical question.

✓ DEXA is the right choice when…

  • Osteoporosis diagnosis: DEXA is the gold standard, providing T-scores and Z-scores that define osteopenia and osteoporosis by WHO criteria.
  • Treatment monitoring: serial DEXA directly measures whether bisphosphonate or other therapy is increasing bone density.
  • Fracture risk quantification: BMD values input to FRAX generate quantitative fracture probability estimates.

⚠ Consider a different modality when…

  • Bone quality and microarchitecture: DEXA measures density only; high-resolution peripheral QCT or bone biopsy needed for true microarchitectural assessment.
  • Existing vertebral fractures: lateral spine X-ray or vertebral fracture assessment (VFA) identifies compression fractures that independently elevate fracture risk.
  • Metabolic bone disease (Paget's, hyperparathyroidism): bone scan and biochemical markers provide additional information DEXA cannot.
+ Technical strengths, limitations & patient preparation

Strengths

  • Gold standard for osteoporosis diagnosis and monitoring
  • Fast (10–20 minutes), comfortable, non-invasive
  • Negligible radiation dose
  • T-score drives guideline-based treatment decisions
  • Can assess body composition (fat vs. lean mass)

Limitations

  • Measures density only — not bone quality or microarchitecture
  • Degenerative spinal changes and aortic calcification can falsely elevate lumbar spine BMD
  • Scanner-specific — ideally monitor on the same machine over time

📋 Patient Preparation

No fasting required. Avoid calcium supplements for 24 hours beforehand. Remove metal from the scan area. Recent nuclear medicine or contrast studies can occasionally affect results.

Common Indications

Clinical scenarios in which DEXA Bone Density Scan is typically ordered:

  • Women age 65 and older — USPSTF routine screening
  • Postmenopausal women under 65 with risk factors
  • Men age 70 and older
  • Adults with fracture after minimal trauma
  • Long-term corticosteroid use (≥3 months)
  • Secondary osteoporosis (hyperparathyroidism, malabsorption, hypogonadism)
  • Monitoring response to osteoporosis treatment (typically every 1–2 years)
  • Initiation or discontinuation of osteoporosis medications

Contrast Protocols

When to order each protocol for DEXA Bone Density Scan:

Standard Protocol No contrast or injection required.

Prior Authorization Overview

Typical requirement: Prior auth requirements vary. Screening DEXA for eligible patients (women ≥65, men ≥70, postmenopausal women with risk factors) is often covered as preventive care. Monitoring frequency (typically every 1–2 years) is the main prior auth consideration.

✓ Key Approval Criteria

  • Screening: document age and risk factors per USPSTF/NOF guidelines
  • Monitoring: document prior DEXA results and treatment being monitored
  • Frequency: most payers follow 1–2 year intervals; shorter intervals require documentation
  • Steroid-induced: document duration and dose of corticosteroid therapy

⚠ Common Denial Pitfalls

  • DEXA within 1 year of prior study without documented reason for early repeat
  • Not documenting clinical risk factors for non-age-based indications
  • Ordering appendicular DEXA (77081) when axial is the clinically appropriate standard

Frequently Asked Questions

Need to check authorization for DEXA Bone Density Scan?

Use Nakod's coverage lookup to verify PA requirements in real time.

Check Coverage →